944994-03-0

Basic information

• Product Name: 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester
• Synonyms: 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester;1-(methylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;(1-(METHYLSULFONYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 944994-03-0
• Molecular Formula: C10H19BN2O5S
• Molecular Weight: 290.14426
• Mol File: 944994-03-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester(944994-03-0)
• EPA Substance Registry System: 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester(944994-03-0)

Safety Data

• Hazardous Substances Data: 944994-03-0(Hazardous Substances Data)

Usage

Uses

Used in Chemical Research:
1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester is used as a research chemical for the development and study of novel chemical reactions and synthetic pathways. Its unique structure allows for exploration of its reactivity and potential applications in various chemical processes.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester is used as a key intermediate in the synthesis of various drug candidates. Its ability to form stable boron-containing compounds makes it a promising candidate for the development of new pharmaceutical agents with potential therapeutic applications.
Used in Material Science:
1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester is also utilized in material science for the development of new materials with unique properties. Its boron-containing structure can contribute to the creation of materials with enhanced thermal stability, electrical conductivity, or other desirable characteristics.
Overall, 1-(Methylsulfonyl)pyrazole-4-boronic acid pinacol ester is a versatile research chemical with potential applications across various industries, including pharmaceuticals, chemical research, and material science. Its unique structure and reactivity make it a valuable tool for the development of new compounds and materials with a wide range of applications.

Upstream product

• 269410-08-4 pyrazole-4-boronic acid pinacol ester 
• 124-63-0 methanesulfonyl chloride 

Relevant articles and documents

AZAINDOLE DERIVATIVE AND USE THEREOF AS FGFR AND C-MET INHIBITOR

A series of pyrazolopymidine derivatives, and use thereof in the preparation of a medicament for treating disease associated with FGFR and c-Met. The pyrazolopymidine derivative is a compound represented by formula (I), a tautomer, or a pharmaceutically acceptable salt thereof.

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

Disclosed are compounds of Formula (I) or a stereoisomer, a tautomer, or a salt or solvate thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor (FXR), for example, as agonists. Also disclosed are pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.

Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor

Inhibitors targeting the activating mutants of the epidermal growth factor receptor (EGFR) have found success in the treatment of EGFR mutant positive non-small-cell lung cancer. A secondary point mutation (T790M) in the inhibitor binding site has been li

PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS

Provided are compounds according to Formula (I), or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R1, R6 , R7, and R8 are as defined, which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PB -kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.

THIAZOLE DERIVATIVES AND USE THEREOF

The present invention is related to thiazole derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infect